Active substanceLevocarnitineLevocarnitine
Similar drugsTo uncover
  • Carnithen
    solution inwards 
  • Carnithen
    solution in / in 
  • Carnithen
    pills inwards 
  • L-Carnitine Rompharm
    solution w / m in / in 
  • Levocarnil®
    solution inwards 
    EVALAR, CJSC     Russia
  • Nephrocaritoneum
    solution inwards 
  • Elkar®
    solution w / m in / in 
    PIK-PHARMA, LLC     Russia
  • Elkar®
    solution inwards 
    PIK-PHARMA, LLC     Russia
  • Elkar®
    solution inwards 
    PIK-PHARMA, LLC     Russia
  • Elkar®
    granules inwards 
    PIK-PHARMA, LLC     Russia
  • Dosage form: & nbsporal solution
    Composition:

    To 10 ml of solution:

    Active substance: Levocarnitine 1.0 g

    Auxiliary components: acid d,-l apple (2-hydroxybutadione), sodium benzoate, sodium saccharinate dihydrate, distilled water.

    Description:Transparent colorless liquid.
    Pharmacotherapeutic group:Metabolic means
    ATX: & nbsp

    A.16.A.A   Amino acids and their derivatives

    A.16.A.A.01   Levocarnitine

    Pharmacodynamics:

    Levokarnitin - a remedy for the correction of metabolic processes. This is a natural substance related to vitamins of group B.Participates in metabolic processes as a carrier of fatty acids through cell membranes from the cytoplasm to the mitochondria, where these acids undergo oxidation with the formation of a large amount of energy (in the form of ATP). It normalizes protein and fat metabolism, restores alkaline blood reserves, inhibits the formation of keto acids and anaerobic glycolysis, reduces the degree of lactic acidosis, and also increases motor activity and increases the tolerance of exercise, while contributing to the economical consumption of glycogen and its increase in the liver. There are no cases of habituation or metabolic dependence.

    Indications:

    Primary and secondary deficiency of carnitine. Disturbance of metabolism in the myocardium in the case of ischemic cardiopathy: angina pectoris, postinfarction state.

    Contraindications:Hypersensitivity to the components of the drug.
    Carefully:In patients with diabetes mellitus.
    Pregnancy and lactation:

    The drug can be used during pregnancy and breastfeeding.

    Dosing and Administration:

    Inside

    Primary and secondary deficiency in genetic diseases:

    Daily oral dose, depending on age and body weight: from 0 to 2 years, 150 mg (1.5 ml of solution) per kg of body weight is recommended, from 2-6 years - 100 mg (1 ml of solution) per kg of body weight, from 6 to 12 years - 75 mg (0.75 ml of the drug) per kg of body weight, from 12 years and adults - from 2 to 4 g (20 to 40 ml of the drug), depending on the severity of the pathology and the doctor's recommendations.

    Secondary deficiency in hemodialysis: from 2 to 4 g per day (from 20 to 40 ml of the drug).

    Angina and postinfarction states: from 2 to 6 g per day (from 20 to 60 ml of the drug) on ​​the recommendation of a doctor.

    The contents of the single-dose vial should be dissolved in a glass of water, regardless of the meal.

    Side effects:

    Possible mild gastrointestinal disorders (pain in epigastrium, flatulence, diarrhea, constipation) after ingestion, allergic reactions. Muscular weakness was noted in patients suffering from uremia. If any undesirable effect is not described in the instructions for use, it is necessary to contact your doctor in time.

    Overdose:Toxic manifestations due to an overdose of levocarnitine have not been established.
    Interaction:Glucocorticosteroids contribute to the accumulation of the drug in the tissues.
    Special instructions:

    The administration of levocarnitine to patients suffering from diabetes mellitus and receiving insulin or other oral hypoglycemic agents may lead to the development of Hypoglycemia associated with improved glucose uptake. Therefore, these patients should monitor blood glucose levels for timely correction of a dose of hypoglycemic drugs.

    Form release / dosage:Solution for oral administration 1g / 10 ml.
    Packaging:

    For 10 ml of solution in a bottle of dark yellow glass.

    The bottle is sealed with a plastic stopper. 10 bottles with instructions for use in a cardboard box.

    Storage conditions:

    Store at a temperature not higher than 25 ° C, out of the reach of children.

    Shelf life:

    5 years. Do not use after expiry date.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N011461 / 02
    Date of registration:04.04.2008
    Expiration Date:Unlimited
    The owner of the registration certificate:Sigma-Tau United Pharmaceutical Industries SpASigma-Tau United Pharmaceutical Industries SpA Italy
    Manufacturer: & nbsp
    Representation: & nbspPharma Riace Co., Ltd. Pharma Riace Co., Ltd. United Kingdom
    Information update date: & nbsp14.12.2017
    Illustrated instructions
      Instructions
      Up